Mark S. Sands
Affiliations: | Washington University, Saint Louis, St. Louis, MO |
Area:
Molecular geneticsWebsite:
http://dbbs.wustl.edu/DBBS/website.nsf/RIB/5EE729EE796AEAE086256D4E005B2DAFGoogle:
"Mark Sands"Mean distance: 12883.8 (cluster 6)
Cross-listing: Neurotree
Children
Sign in to add trainee| Adarsh Reddy | grad student | 2004- | Washington University |
| Megan A. Griffey | grad student | 2004 | Washington University (Neurotree) |
| August A. Hofling | grad student | 2005 | Washington University (Neurotree) |
| Anthony Donsante | grad student | 2006 | Washington University (Neurotree) |
| Josh C. Woloszynek | grad student | 2007 | Washington University (Neurotree) |
| Shannon L. Macauley-Rambach | grad student | 2009 | Washington University (Neurotree) |
| Jacqueline A. Hawkins | grad student | 2012 | Washington University (Neurotree) |
| Charles Shyng | grad student | 2010-2016 | Washington University (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Takahashi K, Eultgen EM, Wang SH, et al. (2023) Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse model. The Journal of Clinical Investigation |
| Nelvagal HR, Eaton SL, Wang SH, et al. (2022) Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep. The Journal of Clinical Investigation |
| Babcock MC, Mikulka CR, Wang B, et al. (2021) Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. Scientific Reports. 11: 14486 |
| Bradbury AM, Bongarzone ER, Sands MS. (2021) Krabbe Disease: New Hope for an Old Disease. Neuroscience Letters. 135841 |
| Heller GJ, Marshall MS, Issa Y, et al. (2021) Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Li Y, Miller CA, Shea LK, et al. (2020) Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe disease. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Nelvagal HR, Hurtado ML, Eaton SL, et al. (2020) Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease. Scientific Reports. 10: 15157 |
| Nelvagal HR, Dearborn JT, Ostergaard JR, et al. (2020) Spinal manifestations of CLN1 disease start during the early postnatal period. Neuropathology and Applied Neurobiology |
| Bradbury AM, Bagel JH, Nguyen D, et al. (2020) Krabbe disease successfully treated via monotherapy of intrathecal gene therapy. The Journal of Clinical Investigation |
| Mikulka CR, Dearborn JT, Benitez BA, et al. (2020) Cell-autonomous expression of the acid hydrolase galactocerebrosidase. Proceedings of the National Academy of Sciences of the United States of America |